Search Page

1

Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in Non-Small Cell Lung Cancer.

Al-Samkari H, Leiva O, Dagogo-Jack I, Shaw A, Lennerz J, Iafrate AJ, Bendapudi PK, Connors JM. Al-Samkari H, et al. Among authors: Bendapudi PK. J Thorac Oncol. 2020 May 10:S1556-0864(20)30380-4. doi: 10.1016/j.jtho.2020.04.033. Online ahead of print. J Thorac Oncol. 2020. PMID: 32437899

Cite

Share

2

Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura.

Colling M, Sun L, Upadhyay V, Ryu J, Li A, Uhl L, Kaufman RM, Stowell CP, Dzik WH, Makar RS, Bendapudi PK. Colling M, et al. Among authors: Bendapudi PK. Transfusion. 2020 Apr;60(4):841-846. doi: 10.1111/trf.15721. Epub 2020 Feb 21. Transfusion. 2020. PMID: 32080877

Cite

Share

3

Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative.

Upadhyay VA, Geisler BP, Sun L, Uhl L, Kaufman RM, Stowell C, Makar RS, Bendapudi PK. Upadhyay VA, et al. Among authors: Bendapudi PK. Br J Haematol. 2019 Aug;186(3):490-498. doi: 10.1111/bjh.15932. Epub 2019 May 26. Br J Haematol. 2019. PMID: 31131442

Cite

Share

4

Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura.

Sun L, Mack J, Li A, Ryu J, Upadhyay VA, Uhl L, Kaufman RM, Stowell CP, Dzik WS, Makar RS, Bendapudi PK. Sun L, et al. Among authors: Bendapudi PK. Blood Adv. 2019 May 14;3(9):1512-1518. doi: 10.1182/bloodadvances.2019031039. Blood Adv. 2019. PMID: 31076407 Free PMC article.

Cite

Share

5

Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate.

Bendapudi PK, Robbins A, LeBoeuf N, Pozdnyakova O, Bhatt A, Duke F, Sells R, McQuiston J, Humrighouse B, Rouaisnel B, Colling M, Stephenson KE, Saavedra A, Losman JA. Bendapudi PK, et al. Blood Adv. 2018 Nov 13;2(21):2917-2921. doi: 10.1182/bloodadvances.2018024430. Blood Adv. 2018. PMID: 30396911 Free PMC article. No abstract available.

Cite

Share

6

Perioperative management of a redo aortic root replacement in a patient with severe factor XI deficiency.

Fitzsimons MG, Leaf RK, Mack J, Bendapudi PK, Shen T, Cameron DE. Fitzsimons MG, et al. Among authors: Bendapudi PK. J Card Surg. 2018 Feb;33(2):86-89. doi: 10.1111/jocs.13526. Epub 2018 Feb 4. J Card Surg. 2018. PMID: 29399875

Cite

Share

7

Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis.

Colling ME, Bendapudi PK. Colling ME, et al. Among authors: Bendapudi PK. Transfus Med Rev. 2018 Apr;32(2):69-76. doi: 10.1016/j.tmrv.2017.10.001. Epub 2017 Oct 16. Transfus Med Rev. 2018. PMID: 29157918 Review.

Cite

Share

8

Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.

Li A, Bendapudi PK, Uhl L, Hamdan A, Kaufman RM, Makar RS. Li A, et al. Among authors: Bendapudi PK. Transfusion. 2017 Sep;57(9):2151-2158. doi: 10.1111/trf.14181. Epub 2017 Jun 20. Transfusion. 2017. PMID: 28635017

Cite

Share

9

Clinical Scoring Systems in Thrombotic Microangiopathies.

Bendapudi PK, Upadhyay V, Sun L, Marques MB, Makar RS. Bendapudi PK, et al. Semin Thromb Hemost. 2017 Jul;43(5):540-548. doi: 10.1055/s-0037-1603100. Epub 2017 Jun 8. Semin Thromb Hemost. 2017. PMID: 28597458 Review. No abstract available.

Cite

Share

10

Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.

Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A, Sun L, Upadhyay V, Hamdan A, Brunner AM, Gansner JM, Viswanathan S, Kaufman RM, Uhl L, Stowell CP, Dzik WH, Makar RS. Bendapudi PK, et al. Lancet Haematol. 2017 Apr;4(4):e157-e164. doi: 10.1016/S2352-3026(17)30026-1. Epub 2017 Mar 2. Lancet Haematol. 2017. PMID: 28259520

Cite

Share